Viruses as precipitants of asthma symptoms III. Rhinoviruses: molecular biology and prospects for future intervention

In the first twoarticlesin this series [1,2], we examined the epidemiological evidence for an association between respiratory viral infections and asthma exacerbations, and the physiological and experimental evidence for the proposed cellular and biochemical mechanisms involved in this association. As mentioned in Part I, most previous studies have indicated that rhinoviruses are the most common viruses associated with wheezing illness (except in infancy), and are also among the viruses with the greatest propensity to trigger wheezing or asthma attacks. Our own studies among children with recurrent wheeze and/or cough suggested that rhinoviruses may be found in as many as half of all such episodes of respiratory illness—six times as common as the next most common virus [3]. This last article in the series will review recent developments in the molecular biology of rhinoviruses and their receptors, and will examine the potential for preventing or ameliorating attacks precipitated by viral infections.

[1]  S. Johnston,et al.  Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms , 1993, Journal of clinical microbiology.

[2]  P. Howarth,et al.  The expression of leukocyte-endothelial adhesion molecules is increased in perennial allergic rhinitis. , 1992, American journal of respiratory cell and molecular biology.

[3]  S. Johnston,et al.  Viruses as precipitants of asthma symptoms II. Physiology and mechanisms , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[4]  S. Johnston,et al.  Viruses as precipitants of asthma symptoms. I. Epidemiology , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  K. Andries,et al.  In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity , 1992, Antimicrobial Agents and Chemotherapy.

[6]  V. Agol,et al.  The 5′-Untranslated Region of Picornaviral Genomes , 1991, Advances in Virus Research.

[7]  D. Tyrrell,et al.  Prophylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory disease. , 1991, Thorax.

[8]  M. Makgoba,et al.  Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders , 1991, The Lancet.

[9]  J. Burgess Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers , 1991 .

[10]  M. Kramer,et al.  Risks and benefits of paracetamol antipyresis in young children with fever of presumed viral origin , 1991, The Lancet.

[11]  S. Holgate,et al.  Adhesion molecules and their role in inflammation. , 1991, Respiratory medicine.

[12]  O. Ruuskanen,et al.  Clinical role of respiratory virus infection in acute otitis media , 1990, International Journal of Pediatric Otorhinolaryngology.

[13]  K. Bloch,et al.  582 Failure of inhibitors of formation or enhancers of degradation of toxic oxygen products to prevent immune complex(IC)-induced enteropathy , 1991 .

[14]  P. Howarth,et al.  285 Bronchial mucosal intercellular adhesion molecule-1 [ICAM-1] and endothelial leukocyte adhesion molecule-1 [ELAM-1] expression in normals and asthmatics , 1991 .

[15]  D. Tyrrell,et al.  A study of the efficacy of the bradykinin antagonist, NPC 567, in rhinovirus infections in human volunteers , 1990, Antiviral Research.

[16]  N. Graham,et al.  ADVERSE EFFECTS OF ASPIRIN. ACETAMINOPHEN, AND IBUPROFEN ON IMMUNE FUNCTION, VIRAL SHEDDING, AND CLINICAL STATUS ON RHINOVIRUS‐INFECTED VOLUNTEERS , 1990, The Journal of infectious diseases.

[17]  R. Naclerio,et al.  A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. , 1990, The Journal of infectious diseases.

[18]  D. M. Olive,et al.  Detection and differentiation of picornaviruses in clinical samples following genomic amplification. , 1990, The Journal of general virology.

[19]  D. Boldy,et al.  Acute bronchitis in the community: clinical features,infective factors, changes in pulmonary function and bronchial reactivity to histamine , 1990, Respiratory Medicine.

[20]  D. Tyrrell,et al.  Pathogenicity for humans of human rhinovirus type 2 mutants resistant to or dependent on chalcone Ro 09-0410 , 1990, Antimicrobial Agents and Chemotherapy.

[21]  Michael Loran Dustin,et al.  The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus , 1990, Cell.

[22]  M. Silverman,et al.  Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home. , 1990, Archives of disease in childhood.

[23]  P. Lewi,et al.  Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity , 1990, Journal of virology.

[24]  D. Staunton,et al.  A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection , 1990, Nature.

[25]  J. Condra,et al.  Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cells. , 1990, Journal of Biological Chemistry.

[26]  R. Rothlein,et al.  Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. , 1990, Science.

[27]  B. E. Huber,et al.  3-deazaadenosine inhibits leukocyte adhesion and ICAM-1 biosynthesis in tumor necrosis factor-stimulated human endothelial cells. , 1990, Journal of immunology.

[28]  D. Tyrrell,et al.  The effect of intranasal nedocromil sodium on viral upper respiratory tract infections in human volunteers , 1990, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[29]  P. Auvinen,et al.  Polymerase chain reaction for human picornaviruses. , 1989, The Journal of general virology.

[30]  M. Rossmann Neutralization of small RNA viruses by antibodies and antiviral agents 1 , 1989, The FASEB Journal.

[31]  R. Rothlein,et al.  The effect of anti-intercellular adhesion molecule-1 on phorbol-ester-induced rabbit lung inflammation. , 1989, Journal of immunology.

[32]  J. Tomassini,et al.  cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[33]  G. Stanway,et al.  Amplification of rhinovirus specific nucleic acids from clinical samples using the polymerase chain reaction , 1989, Journal of medical virology.

[34]  D. Tyrrell,et al.  Local hyperthermia benefits natural and experimental common colds. , 1989, BMJ.

[35]  A. Treasurywala,et al.  Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors , 1989, Journal of virology.

[36]  A. Mcclelland,et al.  The major human rhinovirus receptor is ICAM-1 , 1989, Cell.

[37]  D. Staunton,et al.  A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses , 1989, Cell.

[38]  J. Vadolas,et al.  Mapping of neutralization epitopes of human rhinovirus type 2 with monoclonal antibodies , 1989 .

[39]  D. Tyrrell,et al.  Recombinant Human Interferon-γ as Prophylaxis Against Rhinovirus Colds in Volunteers , 1988 .

[40]  R. Rothlein,et al.  Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies. , 1988, Journal of immunology.

[41]  M. Murcko,et al.  Evidence for the direct involvement of the rhinovirus canyon in receptor binding. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[42]  F. Hayden,et al.  Modification of experimental rhinovirus colds by receptor blockade. , 1988, Antiviral research.

[43]  R. Colonno,et al.  Characterization of human rhinoviruses displaced by an anti-receptor monoclonal antibody , 1988, Journal of virology.

[44]  M. Rossmann,et al.  Conservation of the putative receptor attachment site in picornaviruses. , 1988, Virology.

[45]  L. Lands,et al.  Childhood asthma: prevention of attacks with short-term corticosteroid treatment of upper respiratory tract infection. , 1988, Pediatrics.

[46]  F. Hayden,et al.  Chemotherapy of rhinovirus colds , 1988, Antimicrobial Agents and Chemotherapy.

[47]  H. Mischak,et al.  Characteristics of the minor group receptor of human rhinoviruses. , 1988, Virology.

[48]  R. Naclerio,et al.  Kinins are generated during experimental rhinovirus colds. , 1988, The Journal of infectious diseases.

[49]  P. Minor,et al.  The nucleotide sequence of human rhinovirus 1B: molecular relationships within the rhinovirus genus. , 1988, The Journal of general virology.

[50]  D. Tyrrell,et al.  A 'new' generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactions. , 1987, Antiviral research.

[51]  W. S. Jordan,et al.  A collaborative report: rhinoviruses--extension of the numbering system from 89 to 100. , 1987, Virology.

[52]  W. Sommergruber,et al.  Evolutionary relationships within the human rhinovirus genus: comparison of serotypes 89, 2, and 14. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[53]  W. Lenney,et al.  EFFECT OF A SINGLE ORAL DOSE OF PREDNISOLONE IN ACUTE CHILDHOOD ASTHMA , 1987, The Lancet.

[54]  F. Hayden Prevention of natural colds by contact prophylaxis with intranasal alpha2-interferon. , 1986 .

[55]  K. Mcintosh,et al.  The association of rhinoviruses with lower respiratory tract disease in hospitalized patients , 1986, Journal of medical virology.

[56]  B. Rosenwirth,et al.  Molecular cloning and sequence determination of the genomic regions encoding protease and genome-linked protein of three picornaviruses , 1986, Journal of virology.

[57]  F. Hayden,et al.  Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. , 1986, The New England journal of medicine.

[58]  J. Albrecht,et al.  Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting. , 1986, The New England journal of medicine.

[59]  R. Colonno,et al.  Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses , 1986, Journal of virology.

[60]  A. Milner,et al.  Oral corticosteroids for wheezing attacks under 18 months. , 1986, Archives of disease in childhood.

[61]  John E. Johnson,et al.  Structure of a human common cold virus and functional relationship to other picornaviruses , 1985, Nature.

[62]  F. Fraundorfer,et al.  Human rhinovirus 2: complete nucleotide sequence and proteolytic processing signals in the capsid protein region. , 1985, Nucleic acids research.

[63]  R. Mountford,et al.  The complete nucleotide sequence of a common cold virus: human rhinovlrus 14 , 1984 .

[64]  R. Mountford,et al.  The complete nucleotide sequence of a common cold virus: human rhinovirus 14. , 1984, Nucleic acids research.

[65]  F. Hayden,et al.  Human tolerance and histopathologic effects of long-term administration of intranasal interferon-alpha 2. , 1983, The Journal of infectious diseases.

[66]  D. Tyrrell,et al.  Isolation of rhinoviruses and coronaviruses from 38 colds in adults , 2005, Journal of medical virology.

[67]  I. Gregg,et al.  A study of infective and other factors in exacerbations of chronic bronchitis , 1980, British Journal of Diseases of the Chest.

[68]  I. Wickings Putting it together. The patient, the purse, and the practice. , 1977, Lancet.

[69]  H. Lambert,et al.  Infective Factors in Exacerbations of Bronchitis and Asthma , 1972, British medical journal.

[70]  D. Taylor-Robinson LABORATORY AND VOLUNTEER STUDIES ON SOME VIRUSES ISOLATED FROM COMMON COLDS (RHINOVIRUSES). , 1963, American Review of Respiratory Disease.

[71]  D. Tyrrell,et al.  Some virus isolations from common colds. III. Cytopathic effects in tissue cultures. , 1960, Lancet.